BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed CORT catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:88b7b9fce7aec5af3f95@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:CORT P2 readout (est.): Extension Study to Evaluate the Safety of L
 ong-Term Use of Relacorilant in Patients With Cushing Syndrome
DESCRIPTION:Extension Study to Evaluate the Safety of Long-Term Use of Rela
 corilant in Patients With Cushing Syndrome\nNCT03604198 | PHASE2 | ACTIVE_
 NOT_RECRUITING | sponsor: Corcept Therapeutics\nPrimary completion date (E
 STIMATED)\; top-line results usually follow later.\nDate precision: month 
 (shown on the first day)\nTicker CORT (confidence 0.9)\nSource: https://cl
 inicaltrials.gov/study/NCT03604198\nScheduling/reference data from public 
 records\; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT03604198
CATEGORIES:readout,ESTIMATED
END:VEVENT
BEGIN:VEVENT
UID:341f60e32dd4bd47639c@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260326
SUMMARY:CORT APPROVAL: LIFYORLI (COPACKAGED)
DESCRIPTION:Approved 2026-03-25: LIFYORLI (COPACKAGED) (NDA220641 ORIG1)\nC
 onfidence: confirmed\nTicker CORT (confidence 0.6)\nSource: https://www.ac
 cessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=
 220641\nScheduling/reference data from public records\; dates can move. No
 t investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overvie
 w.process&ApplNo=220641
CATEGORIES:approval,confirmed
END:VEVENT
BEGIN:VEVENT
UID:8b99b2d2a9aec18ecb7d@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20260128
DTEND;VALUE=DATE:20260129
SUMMARY:CORT CRL: relacorilant capsules
DESCRIPTION:CRL 2026-01-28: Corcept Therapeutics NDA 219398 (relacorilant c
 apsules)\nConfidence: confirmed\nTicker CORT (confidence 0.9)\nSource: htt
 ps://download.open.fda.gov/crl/CRL_NDA219398_20260128.pdf\nScheduling/refe
 rence data from public records\; dates can move. Not investment\, legal or
  medical advice.
TRANSP:TRANSPARENT
URL:https://download.open.fda.gov/crl/CRL_NDA219398_20260128.pdf
CATEGORIES:crl,confirmed
END:VEVENT
END:VCALENDAR
